External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Infectious Disease ESCMID 2025
Roche and Genentech at

ESCMID 2025

April 11 - April 15
Vienna, Austria
escmid.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
10:00 PM
Duration 90mins Vienna, Austria
Assessment of zosurabalpin activity in combination with other antibiotics
I. Erbetti, D. Sabatini, C. Zampaloni, S. Louvel
Infectious Disease | Antimicrobial resistance

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 90mins Vienna, Austria
Antimicrobial activity of zosurabalpin against a diverse collection of aerobic and anaerobic bacterial and yeast isolates
JM. Maher, B. Roth, AA. Watson, M. Castanheira, C. Zampaloni, S. Louvel
Infectious Disease | Antimicrobial resistance

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 90mins Vienna, Austria
Antibacterial effect of zosurabalpin using simulated human doses against carbapenem resistant Acinetobacter baumannii studied in an in vitro model of infection
P. Griffin, M. Attwood, A. Noel, C. Bissantz, C. Zampaloni, P. Misson, P. Dzgiel, A. Macgowan
Infectious Disease | Antimicrobial resistance

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 90mins Vienna, Austria
Zosurabalpin (5 µg) disk diffusion quality control ranges using Clinical and Laboratory Standards Institute M23 Tier 1 and Tier 2 criteria
M. Huband, Y. Edah, A. Trauner, M. Castanheira
Infectious Disease | Antimicrobial resistance

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 90mins Vienna, Austria
Effect of zosurabalpin, a pathogen-focused antibiotic, on the gut microbiome of healthy participants
P. Scepanovic, M. Anliker-Ort, A. Zipperer, P. Misson, C. Heer, A. Trauner, R. Deurloo, C. Zampaloni, A. Guenther
Infectious Disease | Antimicrobial resistance

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
04:06 PM
Duration 12mins Vienna
Determination of optimal disk diffusion mass for zosurabalpin
Mariana Castanheira
Infectious Disease | Antimicrobial resistance

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
10:00 PM
Duration 90mins Vienna, Austria
Analytical feasibility of the Cobas Eplex gastrointestinal panel: a multiplex PCR syndromic test currently in development
PL. Rodriguez, YJ Li, N Sikhamsay, KL Menge
Infectious Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:30 AM
Duration 10mins Vienna, Austria
Plasma separation card as an alternative sampling method for quantitative HCV RNA testing with high comparability to EDTA plasma
Federico Garcia
Infectious Disease | Hepatitis C virus infection

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.